BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34217185)

  • 1. Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis in liver cirrhosis: systematic review.
    Pimentel R; Gregório C; Figueiredo P
    Acta Gastroenterol Belg; 2021; 84(2):333-342. PubMed ID: 34217185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta-analysis.
    Komolafe O; Roberts D; Freeman SC; Wilson P; Sutton AJ; Cooper NJ; Pavlov CS; Milne EJ; Hawkins N; Cowlin M; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013125. PubMed ID: 31978256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhotic patients with ascites, without gastro-intestinal bleeding.
    Cohen MJ; Sahar T; Benenson S; Elinav E; Brezis M; Soares-Weiser K
    Cochrane Database Syst Rev; 2009 Apr; (2):CD004791. PubMed ID: 19370611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacterial infections in liver cirrhosis].
    Papp M; Farkas A; Udvardy M; Tornai I
    Orv Hetil; 2007 Mar; 148(9):387-95. PubMed ID: 17344166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim-sulfamethoxazole versus norfloxacin in the prophylaxis of spontaneous bacterial peritonitis in cirrhosis.
    Alvarez RF; Mattos AA; Corrêa EB; Cotrim HP; Nascimento TV
    Arq Gastroenterol; 2005; 42(4):256-62. PubMed ID: 16444382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norfloxacin versus alternative antibiotics for prophylaxis of spontaneous bacteria peritonitis in cirrhosis: a systematic review and meta-analysis.
    Song S; Yang Y; Geng C; Tang Z; Wang C; Li X
    BMC Infect Dis; 2023 Aug; 23(1):557. PubMed ID: 37641014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study.
    Assem M; Elsabaawy M; Abdelrashed M; Elemam S; Khodeer S; Hamed W; Abdelaziz A; El-Azab G
    Hepatol Int; 2016 Mar; 10(2):377-85. PubMed ID: 26660707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.
    Elfert A; Abo Ali L; Soliman S; Ibrahim S; Abd-Elsalam S
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1450-1454. PubMed ID: 27512927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of long-term antibiotic treatments in the primary prophylaxis of spontaneous bacterial peritonitis.
    Facciorusso A; Papagiouvanni I; Cela M; Buccino VR; Sacco R
    Liver Int; 2019 Aug; 39(8):1448-1458. PubMed ID: 30920712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASEPTIC: primary antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis-study protocol for an interventional randomised controlled trial.
    Crocombe D; Ahmed N; Balakrishnan I; Bordea E; Chau M; China L; Corless L; Danquah V; Dehbi HM; Dillon JF; Forrest EH; Freemantle N; Gear DP; Hollywood C; Hunter R; Jeyapalan T; Kallis Y; McPherson S; Munteanu I; Portal J; Richardson P; Ryder SD; Virk A; Wright G; O'Brien A
    Trials; 2022 Sep; 23(1):812. PubMed ID: 36167573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics for prophylaxis of spontaneous bacterial peritonitis: systematic review & Bayesian network meta-analysis.
    Soni H; Kumar-M P; Sharma V; Bellam BL; Mishra S; Mahendru D; Mandavdhare HS; Medhi B; Dutta U; Singh V
    Hepatol Int; 2020 May; 14(3):399-413. PubMed ID: 32266675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-term trimethoprim-sulfamethoxazole prophylaxis on ascites formation, bacterial translocation, spontaneous bacterial peritonitis, and survival in cirrhotic rats.
    Guarner C; Runyon BA; Heck M; Young S; Sheikh MY
    Dig Dis Sci; 1999 Oct; 44(10):1957-62. PubMed ID: 10548343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
    Novella M; Solà R; Soriano G; Andreu M; Gana J; Ortiz J; Coll S; Sàbat M; Vila MC; Guarner C; Vilardell F
    Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Norfloxacin Prophylaxis to Prevent Spontaneous Bacterial Peritonitis: A Systematic Review and Meta-Analysis.
    Mücke MM; Mücke VT; Graf C; Schwarzkopf KM; Ferstl PG; Fernandez J; Zeuzem S; Trebicka J; Lange CM; Herrmann E
    Clin Transl Gastroenterol; 2020 Aug; 11(8):e00223. PubMed ID: 32955202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial.
    Yim HJ; Suh SJ; Jung YK; Yim SY; Seo YS; Lee YR; Park SY; Jang JY; Kim YS; Kim HS; Kim BI; Um SH
    Am J Gastroenterol; 2018 Aug; 113(8):1167-1176. PubMed ID: 29946179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norfloxacin, ciprofloxacin, trimethoprim-sulfamethoxazole, and rifaximin for the prevention of spontaneous bacterial peritonitis: a network meta-analysis.
    Wang W; Yang J; Liu C; Song P; Wang W; Xu H; Xia X
    Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):905-910. PubMed ID: 31107737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled study of trimethoprim-sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients.
    Lontos S; Shelton E; Angus PW; Vaughan R; Roberts SK; Gordon A; Gow PJ
    J Dig Dis; 2014 May; 15(5):260-7. PubMed ID: 24612987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
    Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
    Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Risk of
    Girleanu I; Trifan A; Huiban L; Muzica C; Nemteanu R; Teodorescu A; Singeap AM; Cojocariu C; Chiriac S; Petrea O; Zenovia S; Nastasa R; Cuciureanu T; Stanciu C
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577887
    [No Abstract]   [Full Text] [Related]  

  • 20. The efficacy and the immunomodulatory effect of rifaximin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic Egyptian patients.
    Mostafa T; Badra G; Abdallah M
    Turk J Gastroenterol; 2015 Mar; 26(2):163-9. PubMed ID: 25835116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.